KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication

KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication

Kaposi’s sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi’s sarcoma, primary effusion lymphoma and multicentric Castleman’s disease. Since the discovery of KSHV 20 years ago, there is still no standard treatment and the management of virus-associated malignancies remains toxic...

Full description

Bibliographic Details
Main Authors: Natacha Coen, Sophie Duraffour, Robert Snoeck, Graciela Andrei
Format: Article
Language:English
Published: MDPI AG 2014-11-01
Series:Viruses
Subjects:
KSHV
antiviral
nucleoside analog
DNA polymerase inhibitors
lytic cycle
ganciclovir
cidofovir
foscarnet
Online Access:http://www.mdpi.com/1999-4915/6/11/4731

Internet

http://www.mdpi.com/1999-4915/6/11/4731

Similar Items